DEXWireNews

Palantir (NYSE:PLTR) Gradually Makes Way to Two-year High

Long
NYSE:PLTR   Palantir Technologies Inc.
Palantir (PLTR) stock rose above $20.24 – the high from August 1 – on Friday as the artificial intelligence (AI) company attempts to finish off its third straight week of gains. This is the highest level that PLTR stock has traded at since November 2021. PLTR stock progressively rose throughout the session to more than 3%, reaching an intraday high of $20.45.

Palantir stock news
Much of the news surrounding Palantir at the moment stems from hedge funds and family offices filing their 13Fs for the third quarter with the Securities & Exchange Commission (SEC) this week. PLTR stock is a common holding of many of them.

Most notably, Palantir co-founder Peter Thiel’s Mithril venture capital fund sold $48 million worth of Palantir stock in the third quarter, which ended in September. The shares were acquired about a decade ago.

Coatue Management, run by Philippe Laffont, purchased a new position in Palantir. The hedge fund bought just under 894,000 shares of the AI platform company.

Palantir Technical Analysist
Palantir has just barely marked a new two-year high on Friday. The stock has risen as high as $20.34 at the time of writing, 10 cents above the August 1 high of $20.24 and its highest value in two years.

There is no telling how far Palantir stock could rise in the present rally. The 161.8% Fibonacci Extension (not pictured) provides a reading of $22.18 though. The 9-day Simple Moving Average (SMA) is strongly leading its 21-day SMA counterpart, as would be expected in a rally of this type.

Support rests nearby at $18, a level that has been used as both resistance and support since the summer.

⭐⭐⭐ Sign Up for Free ⭐⭐⭐

1) Download our App on Google Play! dexwirenews.com/APP

2) Text Message Notifications: dexwirenews.com/SMS

3) Telegram: t.me/DEXWireNews

4) Follow Us on our Social Networks
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.